MAPT and Cognitive impairment: Our hypothesis was that the PET biomarkers of tau pathology and neuroinflammation are strong predictors of cognitive impairment and decline, and that whereas MRI may be predictive in isolation, the prognostic information of MRI is better captured by direct PET measures of molecular pathology (Bejanin et al., 2017; Mattsson et al., 2019).